LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 340 of 535
Next
>>
>
8476 to 8500 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	TGX221	10	uM	LJP5	1	H19	72	hr	1097	3884	3735	1.0398	1.0447
BT-20	TGX221	10	uM	LJP5	2	H19	72	hr	1097	3982	3877	1.0269	1.0293
BT-20	TGX221	10	uM	LJP5	3	H19	72	hr	1097	4046	3925	1.0307	1.0332
BT-20	GSK1059615	0.04	uM	LJP6	1	C06	72	hr	1097	2996	3610	0.8298	0.7942
BT-20	GSK1059615	0.04	uM	LJP6	2	C06	72	hr	1097	3279	3713	0.8829	0.8633
BT-20	GSK1059615	0.04	uM	LJP6	3	C06	72	hr	1097	3040	3696	0.8224	0.7888
BT-20	GSK1059615	0.04	uM	LJP5	1	E06	72	hr	1097	3280	3735	0.8781	0.8582
BT-20	GSK1059615	0.04	uM	LJP5	2	E06	72	hr	1097	3795	3877	0.9787	0.9764
BT-20	GSK1059615	0.04	uM	LJP5	3	E06	72	hr	1097	3838	3925	0.9777	0.9757
BT-20	GSK1059615	0.12	uM	LJP6	1	C05	72	hr	1097	2447	3610	0.6777	0.5948
BT-20	GSK1059615	0.12	uM	LJP6	2	C05	72	hr	1097	2482	3713	0.6683	0.5905
BT-20	GSK1059615	0.12	uM	LJP6	3	C05	72	hr	1097	2220	3696	0.6006	0.4951
BT-20	GSK1059615	0.12	uM	LJP5	1	E05	72	hr	1097	2666	3735	0.7138	0.6526
BT-20	GSK1059615	0.12	uM	LJP5	2	E05	72	hr	1097	2941	3877	0.7584	0.7183
BT-20	GSK1059615	0.12	uM	LJP5	3	E05	72	hr	1097	2982	3925	0.7597	0.7223
BT-20	GSK1059615	0.37	uM	LJP6	1	C04	72	hr	1097	1860	3610	0.5152	0.3595
BT-20	GSK1059615	0.37	uM	LJP6	2	C04	72	hr	1097	1659	3713	0.4467	0.2649
BT-20	GSK1059615	0.37	uM	LJP6	3	C04	72	hr	1097	1871	3696	0.5062	0.3560
BT-20	GSK1059615	0.37	uM	LJP5	1	E04	72	hr	1097	1464	3735	0.3920	0.1772
BT-20	GSK1059615	0.37	uM	LJP5	2	E04	72	hr	1097	1410	3877	0.3636	0.1476
BT-20	GSK1059615	0.37	uM	LJP5	3	E04	72	hr	1097	1408	3925	0.3587	0.1452
BT-20	GSK1059615	1.11	uM	LJP6	1	C03	72	hr	1097	882	3610	0.2443	-0.1193
BT-20	GSK1059615	1.11	uM	LJP6	2	C03	72	hr	1097	716	3713	0.1928	-0.2155
BT-20	GSK1059615	1.11	uM	LJP6	3	C03	72	hr	1097	729	3696	0.1972	-0.2081
BT-20	GSK1059615	1.11	uM	LJP5	1	E03	72	hr	1097	527	3735	0.1411	-0.3396

|<
<<
Previous
Page 340 of 535
Next
>>
>
8476 to 8500 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)